Old Web
English
Sign In
Acemap
>
Paper
>
In vivo effects of everolimus (RAD), irinotecan (IRI) and combination of the two agents on CRC tumor xenografts.
In vivo effects of everolimus (RAD), irinotecan (IRI) and combination of the two agents on CRC tumor xenografts.
2013
Erica L. Bradshaw-Pierce
Todd M. Pitts
Gillian N. Kulikowski
Heather M. Selby
Andrea L. Merz
Daniel L. Gustafson
Natalie J. Serkova
S. Gail Eckhardt
Colin D. Weekes
Keywords:
Cancer research
Pharmacology
In vivo
Irinotecan
Everolimus
Medicine
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]